Global Drug Infusion Systems Market

Report ID : 1271 | Published : 2022-07-27 | Pages: | Format: PDF/EXCEL

The Global Drug Infusion Systems Market is estimated to reach over USD 23.27 billion by 2030, exhibiting a CAGR of 8.3% during the forecast period. An infusion system is a pump used to administer fluids, nutrients, or medications to a patient's circulatory system. It's usually given intravenously but occasionally used for epidural and arterial infusions. It's often used to manage or treat illnesses or disorders in the neurological system. Increased demand for infusion pumps for infusing drugs or other essential fluids, rising prevalence of fatal diseases and chronic diseases, increased demand for infusion pumps in military and medical units, and advancements in the technology of these surgical drug infusion systems from key market players are all contributing to the global infusion system market's growth. The growing number of chronic diseases, as well as the globe's rapidly ageing population, the ever-increasing demand for ambulatory infusion pumps, and the increasing volume of surgical procedures conducted around the world, are all propelling the infusion pumps market ahead. However, concerns about the systems' consequences and low-income countries' inability to purchase such systems for their medical units are the main roadblocks to the expansion of the global infusion system.

Market Segmentation:

Global Drug Infusion Systems Market is categorized based on product type and application. Based on product, the market is segmented as          Large Volume Infusion Systems, Patient Controlled Analgesia, Elastomeric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Systems, Implantable Infusion Systems, Ambulatory Infusion Systems, and Enteral Infusion Systems. By application, the market is segmented into Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Haematology, Paediatrics, and Other Applications.

Based on application, the diabetes segment is accounted as a major contributor to the Global Drug Infusion Systems Market.

The global drug infusion systems market is divided into paediatrics, diabetes, nutrition, haematology, analgesia, chemotherapy, and others based on application. The diabetes segment is anticipated to lead in terms of revenue share contribution to the worldwide drug infusion systems market during the projected period. Increased use of drug infusion systems for insulin delivery to diabetic patients and an increase in the number of diabetic patients worldwide are driving this segment's expansion. However, revenue growth in the paediatrics category is expected to be strong during the projection period. In the United States, medication overdoses are a major source of concern for healthcare practitioners and providers. Medication errors have been demonstrated to have a more significant impact on paediatric patients, and healthcare professionals are increasingly employing drug infusion systems to reduce the occurrence of medication errors in paediatric patients, which is projected to drive revenue growth in this category.

The insulin Infusion Pumps segment witnessed growth at a rapid rate.

Large Volume Infusion Systems, Patient Controlled Analgesia, Elastomeric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Systems, Implantable Infusion Systems, Ambulatory Infusion Systems, and Enteral Infusion Systems are the product segments of the market. The category is expected to maintain its dominance by expanding significantly during the forecast period. This is due to an increase in the number of type 1 diabetic patients worldwide and the launch of promising technology in the insulin pump field. In the coming years, growing applications of PCA pumps in pain management are expected to drive global product demand.

The North America Global Drug Infusion Systems Market holds a significant revenue share in the region.

Regionally, North America is projected to account for a significant share of the Global Drug Infusion Systems Market in the forecasted period. Higher diabetes diagnosis and treatment rates, increased use of ambulatory pumps, and good reimbursement policies characterize the market in the region. The improvement of medical device technology in the North America region is driving the region's growth. Europe has the second-largest market share. During the period 2022-2030, an increase in the prevalence of chronic diseases in this region, as well as significant expenditure in the healthcare sector by the European Commission, is expected to drive demand for these pumps in Europe. However, the market in growing regions such as Asia Pacific, Latin America, the Middle East and Africa is expected to grow at a faster rate during the projection period. Increased prevalence of chronic diseases such as diabetes and cancer, expanding healthcare infrastructure, rising GDP, increased disposable income, and increased awareness of advanced therapies' availability in the Asia Pacific region are some of the factors expected to drive market growth in the coming years. Latin America's, the Middle East's, and Africa's markets are still in their infancy. Leading businesses' increased focus on expanding their presence, on the other hand, will boost the market in these regions.

Competitive Landscape

The global drug infusion systems market is highly fragmented, with a small number of large and medium-sized companies accounting for most sales. Key players are pursuing various strategies, including mergers and acquisitions, strategic agreements and contracts, and the adoption of more advanced technologies in drug infusion systems solutions. They are also developing, testing, and introducing new and more efficient systems to the market. The following are some of the most well-known players in the worldwide drug infusion systems market: Acromed AG, B. Braun, Melsungen AG, Baxter International Inc.,          Becton, Dickinson and Company, Caesarea Medical Electronics Ltd., Debiotech S.A., Flowonix Medical Inc., Fresenius SE & Co. KGaA, Halyard Health, Inc., ICU Medical Inc., IRADIMED CORPORATION, Insulet Corporation, Medtronic Public Limited Company, MOOG, Inc., Smiths Group plc, Tandem Diabetes Care, Inc., Terumo Corporation, and Zyno Medical, LLC".

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Drug Infusion Systems Market Snapshot

Chapter 4. Global Drug Infusion Systems Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Market Dynamics - Drivers

4.3. Challenges/Restraints

4.4. Market Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. COVID 19 Impact Analysis

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2018 & 2028

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2018 to 2028 for the following Product Type:

5.2.1. Large Volume Infusion Systems

5.2.2. Patient Controlled Analgesia

5.2.3. Elastomeric Infusion Pumps

5.2.4. Insulin Infusion Pumps

5.2.5. Syringe Infusion Systems

5.2.6. Implantable Infusion Systems

5.2.7. Ambulatory Infusion Systems

5.2.8. Enteral Infusion Systems

Chapter 6. Drug Infusion Systems Market Segmentation 2: Application Estimates & Trend Analysis

6.1. Application Analysis & Market Share, 2018 & 2028

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2018 to 2028 for the following Application:

6.2.1. Oncology/Chemotherapy

6.2.2. Diabetes

6.2.3. Analgesia

6.2.4. Nutrition

6.2.5. Haematology

6.2.6. Paediatrics

6.2.7. Other Applications

Chapter 7. Drug Infusion Systems Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.1.2. North America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.1.3. North America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2018-2028

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.2.2. Europe Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.2.3. Europe Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) by country, 2018-2028

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.3.2. Asia Pacific Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.3.3. Asia Pacific Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) by country, 2018-2028

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.4.2. Latin America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.4.3. Latin America Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2018-2028

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.5.2. MEA Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.5.3. MEA revenue Drug Infusion Systems Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2018-2028

7.5.3.1. South Africa

7.5.3.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Acromed AG

8.2.2. B. Braun Melsungen AG

8.2.3. Baxter International Inc.

8.2.4. Becton, Dickinson and Company

8.2.5. Caesarea Medical Electronics Ltd.

8.2.6. Debiotech S.A.

8.2.7. Flowonix Medical Inc.

8.2.8. Fresenius SE & Co. KGaA

8.2.9. Halyard Health, Inc.

8.2.10. ICU Medical Inc.

8.2.11. IRADIMED CORPORATION

8.2.12. Insulet Corporation

8.2.13. Medtronic Public Limited Company

8.2.14. MOOG, Inc.

8.2.15. Smiths Group plc

8.2.16. Tandem Diabetes Care, Inc.

8.2.17. Terumo Corporation

8.2.18. Zyno Medical, LLC

8.3. List of Other Prominent Players

By Product Type-

  • Large Volume Infusion Systems
  • Patient Controlled Analgesia
  • Elastomeric Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Systems
  • Implantable Infusion Systems
  • Ambulatory Infusion Systems
  • Enteral Infusion Systems

By Application Type-

  • Oncology/Chemotherapy
  • Diabetes
  • Analgesia
  • Nutrition
  • Haematology
  • Paediatrics
  • Other Applications

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Drug Infusion Systems Market?

USD 23.27 billion by 2030

CAGR of 8.3% during the forecast period

Our Clients